Lumida
/TMO
⌘K
Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

TMO
$609.82USD+1.10%+6.64 today

MARKET CAP

225.5B

P/E (TTM)

33.5x

FWD P/E

DAY RANGE

$606 – $615

52W RANGE

$435
$647

AI Summary

Stalk
StalkMedium

TMO remains in a medium- and long-term uptrend, trading above its 50- and 200-day SMAs but is experiencing a corrective pullback. Short-term weakness is visible as price oscillates around the 9- and 20-day EMAs with RSI near neutral. We defer execution and stalk for a dip into the 9/20 EMA zone (~606–610) or a retest of the rising 50-day SMA (~578) for a higher-probability bullish entry. A decisive break below the 50-day SMA would invalidate the medium-term bullish bias.

  • Q2 revenue $11.99B (+10% YoY) and adjusted EPS $6.03 (+13%)
  • Raised full-year revenue guidance to $47.4–48.1B and EPS to $24.93–25.33
  • Customers cautious as academic/government budgets are unsettled for 2026
Full analysis →

Buying

15

institutions

Selling

8

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY30.92 M15.50 B+468.94 K+3.6%0.23%
JC

Jpmorgan Chase & Co

Q2 2026

BUY8.50 M4.31 B+1.71 M+32.0%0.25%
FA

Fisher Asset Management, LLC

Q2 2026

BUY2.92 M1.46 B+64.14 K+4.3%0.44%
GM

Grantham, Mayo, Van Otterloo & Co. LLC

Q2 2026

BUY2.74 M1.37 B+236.99 K+11.7%3.10%
VG

Viking Global Investors LP

Q2 2026

BUY1.94 M971.34 M+269.39 K+18.5%2.77%
JH

Janus Henderson Group Plc

Q1 2026

BUY1.32 M649.12 M+223.56 K+2.1%0.16%
CA

Citadel Advisors LLC

Q2 2026

SELL1.13 M565.38 M+-228.00 K-15.2%0.06%
FC

Farallon Capital Management, L.l.c.

Q2 2026

BUYNEW1.05 M526.02 M+1.05 M+0.0%2.44%
FC

Farallon Capital Management LLC

Q1 2026

BUY881.49 K433.28 M+245.80 K+17.6%0.00%
CP

California Public Employees Retirement System

Q2 2026

BUY696.76 K349.33 M+170.00+2.0%0.20%
GC

Glenview Capital Management, LLC

Q2 2026

BUY627.24 K314.47 M+376.71 K+155.4%5.73%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL490.73 K246.03 M+-80.05 K-12.3%0.31%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL426.02 K213.60 M+-1.31 K+1.7%0.33%
WP

Woodline Partners LP

Q2 2026

SELL316.28 K158.57 M+-359.36 K-52.3%0.49%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL300.74 K150.78 M+-78.01 K-19.0%0.17%
MM

Millennium Management LLC

Q2 2026

BUY258.07 K129.39 M+4.78 K+3.9%0.05%
AC

Aqr Capital Management LLC

Q2 2026

BUY257.91 K128.99 M+132.23 K+110.1%0.04%
MG

Man Group Plc

Q2 2026

BUY195.16 K97.85 M+148.76 K+329.0%0.16%
DF

Duquesne Family Office LLC

Q2 2026

BUYNEW19.20 K9.63 M+19.20 K+0.0%0.18%
BA

Bridgewater Associates, LP

Q2 2026

SELL12.95 K6.49 M+-1.54 K-8.8%0.03%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY11.22 K5.63 M+10.49 K+1455.6%0.04%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL10.12 K5.08 M+-126.53 K-92.4%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-138.96 K-100.0%0.00%